Vimarsana
Biggest News Aggregation in the World

Randomized Comparison News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Randomized Comparison. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Randomized Comparison Today - Breaking & Trending Today

CRF Announces TCT 2023 Late-breaking Clinical Trials - Vimarsana News

CRF Announces TCT 2023 Late-breaking Clinical Trials

Annual Scientific Symposium will take place October 23-26 in San Francisco 

Moderate-Intensity Statin With Ezetimibe in Patients With DM and ASCVD - Vimarsana News

Moderate-Intensity Statin With Ezetimibe in Patients With DM and ASCVD

Combination therapy with a moderate-intensity statin and ezetimibe is comparable to high-intensity statin monotherapy in patients with DM and ASCVD.

EDWARDS ANNOUNCES ONE-YEAR DATA ON TRANSFEMORAL TRANSCATHETER TRICUSPID VALVE REPLACEMENT - Vimarsana News

EDWARDS ANNOUNCES ONE-YEAR DATA ON TRANSFEMORAL TRANSCATHETER TRICUSPID VALVE REPLACEMENT

/PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW) announced that one-year results on patients treated in the single-arm, prospective, global,...

EDWARDS ANNOUNCES ONE-YEAR DATA ON TRANSFEMORAL TRANSCATHETER TRICUSPID VALVE REPLACEMENT - Vimarsana News

EDWARDS ANNOUNCES ONE-YEAR DATA ON TRANSFEMORAL TRANSCATHETER TRICUSPID VALVE REPLACEMENT

/PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW) announced that one-year results on patients treated in the single-arm, prospective, global,...

Transcatheter Cardiovascular Therapeutics (TCT) 2022 Conference Preview - Vimarsana News

Transcatheter Cardiovascular Therapeutics (TCT) 2022 Conference Preview

DAIC editors outline some highlights of what to expect from this year’s conference